It was reported that in (b)(6) 2023, a 5x150mm absolute pro was implanted in the moderately calcified right superior femoral artery (sfa).On (b)(6) 2023, the patient was treated for in-stent restenosis confirmed via angiograph and treated with drug eluting balloon.There was no adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
|
The device was not returned for evaluation.A review of the lot history record of the reported lot could not be conducted because the lot number was not provided.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatments appears to be related to the operational context of the procedure.The reported patient effects of restenosis of stented segment is listed in the absolute pro ll peripheral self-expanding stent system instructions for use as a possible complication.There is no indication of a product quality issue with respect to manufacture, design or labeling.D6: implant date has been estimated.
|